The 528 Billion Opportunity Employers, health plans and consumers have made the rising cost of medications a priority. But when medications aren’t appropriate, effective and safe, the human and dollar costs mount even higher. Research published in 2018 demonstrates the…
By Katherine Capps, Co-Founder and Executive Director, GTMRx Institute April 17, 2019 The challenge seems almost insurmountable—advance evidence-based, appropriate use of medication and gene therapies so the right medication reaches the right person at the right time. But today we…
By Katherine Capps, Co-Founder and Executive Director, GTMRx Institute March 18, 2019 Last week, I had the opportunity to witness history—the announcement and video of the largest pharmacogenetic testing effort ever undertaken (check out highlights from the event—you might recognize someone…
April 3, 2018, Vienna, Va. – The high price of prescriptions at the pharmacy counter isn’t the only drug cost problem in the U.S. A new study finds that illness and death resulting from the wrong prescription, the wrong dose,…
By Terry McInnis, president, Blue Thorn Inc. | June 2016 A health care model that yields a positive ROI, improves care and leaves patients and clinicians satisfied? Can't be done, you say? You're close: Few areas in health care can claim…
By Katherine H. Capps, president, Health2 Resources | June 2016 If you want to upset me, tell me "Oh, it's just semantics." Words, and the way we use them, matter. How we label things matters. If you need ibuprofen, you don't…
By Terry McInnis, MD, MPH, CPE, FACOEM, president, Blue Thorn Inc. | May 2016 In May, health care industry insiders and outsiders alike were stunned. A report announced medical errors are the third leading cause of death. Me? I’m not…
May 24, 2016, Vienna, Va.– What if there were experts who worked alongside physicians to adjust and maximize the benefit of all medicines a person takes? Professionals who could help a grandfather control his diabetes and hypertension with fewer side…